HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS3
Switzerland
98933230.9
Filed on 1998-07-09
98933230.9
Filed on 1998-07-09
HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS
Belgium
98933230.9
Filed on 1998-07-09
98933230.9
Filed on 1998-07-09
HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS
Austria
98933230.9
Filed on 1998-07-09
98933230.9
Filed on 1998-07-09
Compound Useful In The Treatment Or Prevention Of Cognitive Disorders Associated With Diabetes And Associated Methods
Chile
2005-2865
Filed on 2005-11-03
2005-2865
Filed on 2005-11-03
Compound Useful In The Treatment Or Prevention Of Cognitive Disorders Associated With Diabetes And Associated Methods
Argentina
P050104610
Filed on 2005-11-03
P050104610
Filed on 2005-11-03
Compound Useful In The Treatment Or Prevention Of Cognitive Disorders Associated With Diabetes And Associated Methods
US Application 11/261,121
Filed on 2005-10-28
Filed on 2005-10-28
Compound Useful In The Treatment Or Prevention Of Cognitive Disorders Associated With Diabetes And Associated Methods
Patent Cooperation Treaty
PCT/US2005/39184
Filed on 2005-10-28
PCT/US2005/39184
Filed on 2005-10-28
Thalidomide Analogs AS TNF-ALPHA Modulators
European Patent
04784385.9
Filed on 2004-09-17
04784385.9
Filed on 2004-09-17
Thalidomide Analogs AS TNF-ALPHA Modulators
Singapore
200601746-1
Filed on 2006-03-08
200601746-1
Filed on 2006-03-08
Thalidomide Analogs AS TNF-ALPHA Modulators
Japan
2006-527059
Filed on 2004-09-17
2006-527059
Filed on 2004-09-17